x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

OncoPharm

OncoPharm is a podcast dedicated to all things oncology pharmacy. Most episodes cover updates and recent publications concerning the use of medications in caring for patients with cancer. Periodically, episodes drop devoted to Landmark Clinical Trials in oncology and Fundamentals of Oncology Pharmacy.

science

All Episodes

00:13:17

PERSEPHONE: Bonus Pod

OncoPharm ·

2018/05/19

The release of ASCO's 2018 annual abstracts resulted in widespread media coverage of PERSEPHONE, the largest trial yet investigating 6 vs. 12 months of adjuvant trastuzumab in breast cancer. We get into the history of adjuvant trastuzumab studies and what to watch for going forward.

en

00:12:09

Cytarabine

OncoPharm ·

2018/05/18

Cytarabine, the 'c' chemotherapy from the sea, is discussed.

en

00:22:03

Dual TKI Use & Frontline Dara

OncoPharm ·

2018/05/10

Recent FDA updates are discussed including combined use of BRAF & MEK inhibitors, frontline daratumumab (10:20), and your next P & T monograph drug to review.

en

00:22:57

Methotrexate

OncoPharm ·

2018/05/04

The foundations of #oncopharm series continues with methotrexate. We begin with its origin story and end discussion modern-day use in high doses.

en

00:37:45

AACR Update

OncoPharm ·

2018/04/19

Recent FDA & #oncopharm updates are discussed, including irinotecan in sweat, fostamatinib's FDA-approval for ITP. Then, immunotherapy updates from AACR are reviewed (6:00). Finally (34:00 , osimertinib's updated approval for frontline use in mEGFR NSCLC.

en

00:11:38

NSABP-14

OncoPharm ·

2018/04/13

You've heard of NSABP, but have you heard of adjuvant melphalan, 5-FU, & concurrent tamoxifen? Sometimes asking the right question yields answers we don't yet understand.

en

00:18:01

Vincristine

OncoPharm ·

2018/04/06

The Foundations in Oncology Pharmacy continues with vincristine. Its origin, unique toxicity profile, and clinical use is discussed. Periwinkle!

en

00:26:08

HOPA Highlights and Catching Up with NEJOncology

OncoPharm ·

2018/03/30

Highlights from last week's HOPA annual conference are discussed, followed by (13:09) a lightning-style run through of #oncopharm updates over the last 2 weeks.

en

00:11:28

HOPA Preview

OncoPharm ·

2018/03/16

Previewing HOPA18 and its highly anticipated sessions, networking opportunities, and virtual attendance.

en

00:22:58

Landmark Testicular Cancer Study PVB (& BEP & EP)

OncoPharm ·

2018/03/09

PVB's (cisplatin, vinblastine, bleomycin) impressive cure rate for testicular cancer is 1977 is discussed. Then the evolution of the BEP & EP regimen is summarized.

en

00:18:28

Cycling thru the CDK Inhibitors

OncoPharm ·

2018/03/01

Abemaciclib's up-front approval provides an opportunity to review all 3 currently FDA-approved CDK 4/6 inhibitors. Dosing, drug interaction, and indication differences are discussed.

en

00:17:23

It's All Immunotherapy Nowadays

OncoPharm ·

2018/02/23

Durvalumab's FDA-approval for NSCLC and the supporting PACIFIC study are discussed, then the ASCO Immunotherapy Toxicity Management Guidelines (7:45) are reviewed. Also, a plug for patient support groups.

en

00:28:38

Apalutamide

OncoPharm ·

2018/02/15

Apalutamide's FDA-approval is discussed, including discussion of its drug interaction potential and a review of the SPARTAN study. Updates (18:15) from ASCO GU and DOAC use in cancer (23:50) also discussed.

en

00:20:58

Landmarks in Oncology Pharmacy: CMF

OncoPharm ·

2018/02/09

The Landmarks series continues with Bonadonna's classic adjuvant CMF regimen in breast cancer in a pre-tamoxifen & pre-ER/PR testing era. Discussion points include number needed to treat (NNT) to prevent recurrence and how chlorambucil was considered for the 'C' in CMF.

en

00:15:16

Foundations in Oncology Pharmacy: Doxorubicin

OncoPharm ·

2018/02/02

Overview of doxorubicin from its Italian origins to its Red Devil alias. Uses and toxicities also discussed, of course.

en

00:14:37

Updates in Oncology Pharmacy: Lu-177

OncoPharm ·

2018/01/26

New Drug Approval: Lutetium-177-dotatate is discussed as well as updates to indications for denosumab (m. myeloma), afatinib, & olaparib.

en

00:17:33

Landmarks in Oncology Pharmacy: MOPP

OncoPharm ·

2018/01/19

The Landmarks series continues with DeVita's original MOPP (Hodgkin's Disease) publication from 1970. Discussion points include WBC monitoring, why cyclophosphamide isn't included, and wigs.

en

00:14:55

Foundations in Oncology Pharmacy: Cisplatin

OncoPharm ·

2018/01/12

The Foundations in Oncology Pharmacy series begins with the penicillin of oncology: cisplatin. Discussion of its history, current uses, & toxicities. Perfect for those new to oncology pharmacy.

en

00:20:20

Updates in Oncology Pharmacy: Adjuvant pertuzumab &...

OncoPharm ·

2018/01/05

Review of recent FDA action re: oncology pharmacy including review of the APHINITIY trial and pertuzumab's subsequent approval in the adjuvant setting. Also, the nilotinib label change allowing for discontinuation in CML patients is discussed.

en

00:14:22

Landmarks in Oncology Pharmacy: Acute Leukemia in 1958

OncoPharm ·

2018/01/01

In the 1st of the Landmarks series, we look back at a pivotal article published in Blood in 1958 on the treatment of acute leukemia.

en

424 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter